Skip to main content
Clinical Trials/NCT02227121
NCT02227121
Terminated
Not Applicable

Acute Defibrillation Study

Medtronic Cardiac Rhythm and Heart Failure7 sites in 4 countries16 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ventricular Arrhythmias
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Enrollment
16
Locations
7
Primary Endpoint
Defibrillation Outcome
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

The proposed study is designed to characterize defibrillation efficacy in humans for the potential development of a new extravascular implantable cardioverter defibrillator (ICD) system.

Detailed Description

The study recruited male and female subjects that met all of the inclusion criteria and none of the exclusion criteria. All subjects were scheduled to undergo surgical procedures outlined in the inclusion criteria. These surgical procedures were chosen as the patient population for this study because these procedures require similar personnel and may require access to similar or the same spaces as the ASD procedure. The entire ASD study research system was removed prior to proceeding with the subject's planned surgery per standard medical practice, which then proceeded according to the standard of care. Subjects were followed through their routine post-surgery follow-up visit. At the time of completing the follow-up visit, the subjects' participation was complete and the subjects exited the study.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject must be undergoing surgical procedure for approved indications for
  • cardiothoracic surgery where a midline sternotomy is planned, or
  • implant of a transvenous (TV) ICD or subcutaneous ICD (S-ICD®), or
  • VT ablation procedure, or
  • VT inducibility testing during Electrophysiology (EP) study
  • Subject must be willing to provide Informed Consent
  • Subject must be ≥ 18 years old

Exclusion Criteria

  • Subject is considered to be at high risk for infection
  • Subject has Left Ventricular Ejection Fraction (LVEF) ≤ 20%
  • Subject at high risk of stroke
  • Subject with an implanted active cardiac or non-cardiac device during study procedure (e.g., ICD, S-ICD®, Pacemaker, Neuro stimulator)
  • Subject is pacemaker dependent
  • Subject had previous pericarditis or prior sternotomy
  • Subject has hiatus hernia or moderate or worse pectus excavatum
  • Subject has hypertrophic cardiomyopathy
  • Subject has severe aortic stenosis
  • Subject has severe proximal three vessel coronary disease (over 70% in each vessel)

Outcomes

Primary Outcomes

Defibrillation Outcome

Time Frame: Day of procedure

Subjects will demonstrate a successful defibrillation outcome if they have a successful defibrillation shock with the research system.

Study Sites (7)

Loading locations...

Similar Trials